New Gene Therapy CMC Guidance from the FDA – A Breakthrough in Regulation or Something More Generic?

An in depth analysis and recommendations for the recently revised cell & gene therapy guidances from our founder and CEO, Anthony Davies, was featured in an editorial for Cell & Gene Therapy Insights.